Paid Clinical Trials Washington State
Discover 1,637 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast CancerOpen-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer
Sponsor:
Stemline Therapeutics, Inc.
Location:
Code:
NCT05563220
Conditions
Breast Cancer
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elacestrant
Alpelisib
Everolimus
Ribociclib
Palbociclib
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05147220
Conditions
Relapsing Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Remibrutinib
Teriflunomide
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular AtherostenosisComparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
Sponsor:
University of Florida
Location:
Code:
NCT05047172
Conditions
Intracranial Arteriosclerosis
Stroke
Eligibility Criteria
Sex: All
Age: 30+
Healthy Volunteers: Not accepted
Interventions
Ticagrelor + Aspirin
Rivaroxaban + Aspirin
Clopidogrel + Aspirin
Risk Factor Management
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal MalignanciesA Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
Sponsor:
Arcus Biosciences, Inc.
Location:
Code:
NCT04104672
Conditions
Advanced Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AB680
Zimberelimab
Nab-paclitaxel
Gemcitabine
Phase 2 Study of NV-5138 in Adults With Treatment Resistant DepressionPhase 2 Study of NV-5138 in Adults With Treatment Resistant Depression
Sponsor:
Navitor Pharmaceuticals, Inc.
Location:
Code:
NCT05066672
Conditions
Treatment Resistant Depression
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
NV-5138
matched placebo
Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
Sponsor:
CinPhloro Pharma, LLC
Location:
Code:
NCT06153420
Conditions
Irritable Bowel Syndrome with Diarrhea
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CIN-103
Placebo
MANATEE-T1D: Metformin and AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth with Type 1 DiabetesMANATEE-T1D: Metformin and AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth with Type 1 Diabetes
Sponsor:
Kalie Tommerdahl
Location:
Code:
NCT05065372
Conditions
Type 1 Diabetes
Diabetic Kidney Disease
Cardiovascular Diseases
Endothelial Dysfunction
Insulin Sensitivity
Eligibility Criteria
Sex: All
Age: 12 - 25
Healthy Volunteers: Not accepted
Interventions
Metformin Hcl 1000Mg Tab
Aminohippurate Sodium 20 % Injection
Iohexol 300 Mg/mL Injectable Solution
Placebo
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Sponsor:
Xynomic Pharmaceuticals, Inc.
Location:
Code:
NCT03592472
Conditions
Renal Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pazopanib
Abexinostat
Placebo
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
Sponsor:
Telix Pharmaceuticals (Innovations) Pty Limited
Location:
Code:
NCT05563272
Conditions
Cervical Cancer
Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Glioblastoma Multiforme
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
89Zr-DFO-girentuximab
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT06750094
Conditions
Colorectal Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Amivantamab
Cetuximab
Bevacizumab
5-fluorouracil
Leucovorin calcium/Levoleucovorin